Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-03-14
1994-12-06
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, 530832, A61K 3702
Patent
active
053710738
ABSTRACT:
IgE binding factors (IgE-bfs) with IgE suppressor (IgE-SF) activity obtainable from human colostrum in an enriched form, a method for the prevention and/or the treatment of allergy by administering the IgE-bfs and pharmaceutical compositions comprising said IgE-bfs.
REFERENCES:
patent: 3553317 (1971-01-01), Michaelson et al.
patent: 4582580 (1986-04-01), Goudal et al.
patent: 4644056 (1987-02-01), Kothe et al.
patent: 4816563 (1989-03-01), Wilson et al.
Richie et al., Journal of Immunology, 129:3 (Sep. 1982) pp. 1116-1119.
Crago et al., Surv. Immunol. Res. 2 (1983) pp. 164-169.
Jarrett, et al. Selective Suppression of IgE Antibody Responsiveness by Maternal Influence, Nature, 280: 145-147 (1979).
Roberts et al., "Specific Suppression of Rat IgE Responses with Milk from Immunized Females and with Feeds of Serum Antibody", Immunology, 48:195-199 (1983).
Burn Brian M.
Ciba-Geigy Corporation
Raymond Richard L.
Spruill W. Murray
LandOfFree
Polypeptide factors from colostrum does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptide factors from colostrum, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide factors from colostrum will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-214528